A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in Northeast Brazil
Launched by CENTRO DE ESTUDOS E PESQUISAS EM MOLESTIAS INFECCIOSAS · Nov 4, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding why some people in Northeast Brazil are hesitant or refuse to get vaccinated. The researchers want to learn more about people's acceptance of vaccines and the reasons behind their decisions. By gathering information from adults over 18 years old living in certain neighborhoods with health challenges, as well as healthcare professionals, the study aims to identify factors that influence vaccination attitudes.
To participate in the study, individuals must be at least 18 years old and live in the neighborhoods of PAJUÇARA, FELIPE CAMARÃO, LAGOA AZUL, or PLANALTO. Participants will be asked to fill out a questionnaire about their views on vaccines. The study is not yet recruiting participants, but once it begins, those who take part can help contribute valuable insights that could improve vaccination rates and public health in their communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals who are over 18 years old and are residents of the PAJUÇARA, FELIPE CAMARÃO, LAGOA AZUL, or PLANALTO neighborhoods, willing to answer the study questionnaire.
- • Healthcare professionals who work in Natal, willing to answer the study questionnaire.
About Centro De Estudos E Pesquisas Em Molestias Infecciosas
Centro de Estudos e Pesquisas em Moléstias Infecciosas is a leading clinical research organization dedicated to advancing the understanding and treatment of infectious diseases. With a commitment to rigorous scientific inquiry and ethical standards, the center conducts innovative clinical trials aimed at evaluating new therapies and improving patient outcomes. Its multidisciplinary team of researchers, clinicians, and public health experts collaborates with various stakeholders to address pressing health challenges, contributing valuable insights to the global fight against infectious diseases. Through its extensive network and expertise, the center plays a pivotal role in translating research findings into effective clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Kleber G Luz, PhD
Principal Investigator
Centro De Estudos E Pesquisas Em Molestias Infecciosas
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported